Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced Tuesday that it had successfully completed a confidential settlement resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:CANSF) (TSX:WLLW).
Aurora Cannabis Inc.（納斯達克股票代碼：ACB）（多倫多證券交易所股票代碼：ACB）週二宣佈，它已成功完成與Willow Biosciences Inc.（OTCQB: CANSF）（多倫多證券交易所股票代碼：WLLW）正在進行的專利訴訟的保密和解。resolving
Aurora undertook the patent infringement action in July 2021, alleging that Willow's biosynthetic process for synthesizing cannabinoids infringed Aurora's exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC).
奧羅拉於2021年7月提起專利侵權訴訟，指控Willow****的生物合成工藝侵犯了Aurora對薩斯喀徹溫大學和國家研究委員會（NRC）共同擁有的專利的專有權。
The technology of the asserted patents was invented by Anandia co-founder and former chief science officer at Aurora, Jonathan Page and his colleagues, following their work at the University of Saskatchewan and the NRC. They identified key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.
所主張的專利的技術是由Anandia聯合創始人兼Aurora前首席科學官喬納森·佩奇及其同事在薩斯喀徹溫大學和核管制委員會工作後發明的。他們鑑定了大麻植物生物合成途徑中的關鍵酶和相應基因。
In December 2022, Willow announced that it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California.
2022年12月，Willow宣佈已整合其研發業務，將設備和關鍵人員從加拿大工廠轉移到加利福尼亞州的山景城。
"We are pleased with the negotiated settlement, which provides Aurora a favorable resolution that ensures our Canadian cannabis-related patent rights are respected," Miguel Martin, CEO of Aurora said. "Aurora is a pioneer in terms of the company's genetics work in the Canadian cannabis industry and will not hesitate to continue to take the steps necessary, including legal action, to protect and enforce our intellectual property rights when necessary."
Aurora首席執行官米格爾·馬丁說：“我們對談判達成的和解感到滿意，這爲Aurora提供了一個有利的解決方案，確保我們與加拿大大麻相關的專利權得到尊重。”“就公司在加拿大大麻行業的遺傳學工作而言，Aurora是先驅，並將毫不猶豫地繼續採取必要措施，包括採取法律行動，在必要時保護和執行我們的知識產權。”
ACB Price Action
ACB 價格走勢
Aurora's shares traded 0.8728% higher at $0.4276 per share at the time of writing on Tuesday morning.
Did you miss the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger's sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
在週二上午撰寫本文時，Aurora的股價上漲0.8728％，至每股0.4276美元。
你錯過了第一波大麻投資浪潮嗎？別再犯那個錯誤了。
專家認爲，大麻庫存已經下限，現在有望實現前所未有的增長。加入 Benzinga Pofits受益於邁克爾·伯傑的敏銳分析，該分析揭示了大麻股票的頂級機會和及時的最新消息。在短短 90 天內體驗 10% 以上回報的潛力。我們的4.5星Marketfy評級足以說明問題。憑藉 30 天退款保證，確保您在這個蓬勃發展的行業中的地位。在其他人意識到之前，現在是投資的時候了。使用 Benzinga 確保您的利潤。立即點擊此處了解更多信息。
Related News
相關新聞
- Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
- Aurora Stock Plunges On $25M Bought Deal To Repay Convertible Debt
- Aurora Cannabis Launches New Brand At Toronto Hall of Flowers, This Is What Innovation Looks Like
- Aurora 和 Curaleaf 大麻公司各完成了數百萬美元的融資協議
- Aurora股價暴跌，收購2500萬美元以償還可轉換債務
- Aurora Cannabis 在多倫多花廳推出新品牌，這就是創新的樣子
Photo: Courtesy of succo, mrkukuruznik5 by Pixabay
照片：由 succo 提供，pixabay 的 mrkukuruznik5
譯文內容由第三人軟體翻譯。